至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Familial primary ovarian insufficiency associated with a SYCE1 point mutation: Defective meiosis elucidated in humanized mice

biorxiv. 2020; 
Diego Hernández-López, Adriana Geisinger, María Fernanda Trovero, Federico F. Santiñaque, Mónica Brauer, Gustavo A. Folle, Ricardo Benavente, Rosana Rodríguez-Casuriaga
Products/Services Used Details Operation
Peptide Synthesis Primary anti-rabbit antibody against SYCE1 amino-terminal region (i.e. capable of detecting WT SYCE1 and its putative truncated form) was developed at GenScript (GenScript USA Inc.), using peptides ATRPQPLGMEPEGSC and CPEGARGQYGSTQKI from the amino-terminal region of the protein. This affinity-purified antibody was employed both for fluorescence microscopy (1:200) and for Western blots (0.3 µg/mL). Get A Quote

摘要

Objective To investigate if nonsense mutation SYCE1 c.613C˃T -found in women with familial primary ovarian insufficiency (POI)- is actually responsible for infertility, and to elucidate the involved molecular mechanisms. Design As most fundamental mammalian oogenesis events occur during the embryonic phase, thus hindering the study of POI’s etiology/pathogeny in infertile women, we have used CRISPR/Cas9 technology to generate a mouse model line with an equivalent genome alteration (humanized mice). Setting Academic research laboratories. Interventions We present the characterization of the biallelic mutant mice phenotype, compared to wild type and monoallelic littermates. Animals Studies were conducted e... More

关键词